Comparison of monotherapy and combination therapy for older patients with advanced biliary tract cancer: a retrospective study
Abstract Background The current standard first-line treatment for patients with advanced biliary tract cancer (BTC) is a combination chemotherapy regimen. However, whether the efficacy of combination therapy is superior to that of monotherapy in older patients with BTC remains unclear. Therefore, in...
Saved in:
| Main Authors: | Ritsuko Oishi, Satoshi Kobayashi, Shuhei Nagashima, Taito Fukushima, Shun Tezuka, Manabu Morimoto, Makoto Ueno, Shin Maeda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14014-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adjuvant Gemcitabine-cisplatin Combination for Biliary Tract Cancer: A Real Life Experience
by: Fatih Kuş, et al.
Published: (2025-08-01) -
Radical resection of an initially unresectable intrahepatic cholangiocarcinoma after chemotherapy with using gemcitabine, cisplatin, and S-1: report of a case
by: Masashi Tsunematsu, et al.
Published: (2019-06-01) -
Addition of gemcitabine to standard therapy in locally advanced cervical cancer: A randomized comparative study
by: Sanjoy Roy, et al.
Published: (2011-01-01) -
CHOICE OF ALTERNATIVE MONOTHERAPY IN EPILEPSY
by: I. Ju. Kovaleva
Published: (2016-05-01) -
Neoadjuvant chemotherapy of invasive bladder cancer
by: S. N. Isayeva, et al.
Published: (2012-04-01)